As of 2025-07-08, the Intrinsic Value of Regeneus Ltd (RGS.AX) is -0.09 AUD. This RGS.AX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.52 AUD, the upside of Regeneus Ltd is -117.58%.
Based on its market price of 0.52 AUD and our intrinsic valuation, Regeneus Ltd (RGS.AX) is overvalued by 117.58%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.09 - -0.09 | -0.09 | -117.58% |
| P/E | (9.47) - (7.62) | (8.59) | -1751.3% |
| DDM - Stable | (4.74) - 32.80 | 14.03 | 2598.2% |
| DDM - Multi | (2.80) - 15.51 | (6.97) | -1441.0% |
| Market Cap (mil) | 4.78 |
| Beta | -2.71 |
| Outstanding shares (mil) | 9.19 |
| Enterprise Value (mil) | 4.75 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.83% |
| Cost of Debt | 5.00% |
| WACC | 5.71% |